- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2010-020860-39. Displaying page 1 of 1.
|EudraCT Number: 2010-020860-39||Sponsor Protocol Number: A5271037||Start Date*: 2010-12-20|
|Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017|
|Full Title: A LONG-TERM OPEN-LABEL EXTENSION STUDY OF LERSIVIRINE FOR THE TREATMENT OF HIV-1 INFECTION|
|Medical condition: Treatment of HIV-1 infection in combination with other agents in antiretroviral treatment naive and antiretroviral treatment-experienced subjects.|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: GB (Prematurely Ended) IT (Prematurely Ended) PT (Prematurely Ended)|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.